ʻO SynerFuse, Inc., kahi hui lāʻau lapaʻau i mālama pono ʻia i ka hoʻomohala ʻana i kahi manaʻo noʻonoʻo neuromodulation therapy no ka mālama ʻana i ka ʻeha hope maʻamau, i kēia lā ua hoʻolaha ka US Patent & Trademark Office (USPTO) i ka US Patent Number. ʻO 11,247,046 i kapa ʻia ʻo nā ʻano hana a me nā ʻōnaehana no ka hoʻokomo ʻana i kahi ʻōnaehana Neuromodulation ma kahi kahua lapaʻau spinal open surgically open. ʻO ka hoʻopuka ʻia ʻana o ka patent '046 e hoʻohui ʻia i ka ulu ʻana o ka ʻoihana patent a puni ka honua i loaʻa i kēia manawa he 63 patent a me nā noi patent i paʻi ʻia.
ʻO ka patent '046 hou i hoʻopuka ʻia e uhi i ka hoʻokomo pololei ʻana o kahi mea neuromodulation ma luna o ka ganglion root dorsal, kahi pahuhopu nerve i ʻike ʻia e hāʻawi i ka hōʻoluʻolu ʻeha i nā patent ke kau ʻia i ka neuromodulation therapy. Hoʻopiha kēia patent i ka patent US 10,675,458 i hoʻopuka mua ʻia, i kapa ʻia ʻo Methods and Systems for Implanting a Neuromodulation System a me kahi Spinal Fixation System ma kahi Surgically Open Spinal Treatment Site, e uhi ana i ka hui pū ʻana o ka spinal fixation a me ka neuromodulation no ka mālama like ʻana o kahi hōʻeha spinal. ʻeha hope mau.
Ua ʻōlelo ʻo Justin Zenanko, ka mea hoʻokumu a me ka luna nui o SynerFuse, "Hoʻohui kēia patent i kā mākou papa inoa patent honua e kākoʻo i ka hoʻomohala ʻana o SynerFuse i kahi manaʻo noʻonoʻo i hoʻohui ʻia no ka mālama ʻana i ka ʻeha mau loa a hoʻohui hou a pale i kā mākou hoʻomau mau ʻana nā hana hoʻoikaika kino a me nā huahana."
"Ke kū nei kekahi mau ʻanuʻu ma kā mākou huakaʻi," wahi a Co-Founder a me Luna Nui ʻepekema ʻo Dr. Greg Molnar. "Ke pale nei kēia patent kūikawā i ka SynerFuse non-narcotic pain management therapy no ka hoʻohana ʻana i ka wā e hiki mai ana i ka lehulehu o ka poʻe maʻi."
ʻO SynerFuse Hope Pelekikena o ka Waiwai Naʻauao Chris Frank, JD; Loio Jeffrey R. Stone o ke keʻena loio ʻoihana ʻo Barnes & Thornburg LLP; a ua alakaʻi ʻo Molnar i nā hoʻoikaika waiwai naʻauao o ka hui.
